Literature DB >> 18941746

Comparison of whole-body MR imaging and conventional X-ray examination in patients with multiple myeloma and implications for therapy.

Dietmar Jörg Dinter1, Wolfgang K Neff, Johanna Klaus, Christoph Böhm, Jan Hastka, Christel Weiss, Stefan O Schoenberg, Georgia Metzgeroth.   

Abstract

Skeletal X-ray survey is the established method of diagnosis in patients with multiple myeloma; however, whole-body magnetic resonance imaging (wb-MRI) has become an important additional tool. The aim of this study was to compare the different patterns of infiltration on conventional X-ray examinations (X-ray survey) with findings from wb-MRI to subsequently determine the influence of wb-MRI on therapy changes. In 60 patients with a mean age of 65.1 +/- 11.7 years, wb-MRI examinations were correlated with a recent X-ray survey. The results were independently assessed by two radiologists and the patterns of infiltration were described in both modalities. Subsequently, the disease was staged according to Salmon and Durie and Salmon and Durie PLUS. Additionally, the influence of MRI on potential changes in therapy was assessed using a three-range Likert-type scale. In all, 480 skeletal regions were compared. In 183 skeletal regions, an increased degree of infiltration was identified on wb-MRI. Significant differences (p < 0.05) between the modalities could be found in the thorax, spine, pelvis, and both lower extremities. Based on wb-MRI, tumor stage was upgraded in 19 of the 60 patients using the Durie and Salmon PLUS classification. In ten out of these 19 patients (42%), the wb-MRI result was essential for making the decision to initiate further therapy due to the degree of infiltration, extramedullary tumor extension, and/or further risk of fracture. Whole-body MRI provides a more detailed assessment of the pattern of bone marrow infiltration and strongly influences therapeutic strategies.

Entities:  

Mesh:

Year:  2008        PMID: 18941746     DOI: 10.1007/s00277-008-0621-6

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  24 in total

1.  Multiple Myeloma presenting as sacroiliac joint pain: a case report.

Authors:  Danielle Southerst; John Dufton; Paula Stern
Journal:  J Can Chiropr Assoc       Date:  2012-06

Review 2.  The uses and limitations of whole-body magnetic resonance imaging.

Authors:  Gerwin Schmidt; Dietmar Dinter; Maximilian F Reiser; Stefan O Schoenberg
Journal:  Dtsch Arztebl Int       Date:  2010-06-04       Impact factor: 5.594

3.  Whole-body MRI and PET/CT in multiple myeloma patients during staging and after treatment: personal experience in a longitudinal study.

Authors:  Giuseppe Lucio Cascini; Carmela Falcone; Domenico Console; Antonino Restuccia; Marco Rossi; Antonello Parlati; Oscar Tamburrini
Journal:  Radiol Med       Date:  2013-06-26       Impact factor: 3.469

Review 4.  The role of positron emission tomography-computed tomography and magnetic resonance imaging in diagnosis and follow up of multiple myeloma.

Authors:  Jo Caers; Nadia Withofs; Jens Hillengass; Paolo Simoni; Elena Zamagni; Roland Hustinx; Yves Beguin
Journal:  Haematologica       Date:  2014-04       Impact factor: 9.941

Review 5.  Musculoskeletal tumors and tumor-like conditions: common and avoidable pitfalls at imaging in patients with known or suspected cancer: Part A: benign conditions that may mimic malignancy.

Authors:  Gary Ulaner; Sinchun Hwang; Robert A Lefkowitz; Jonathan Landa; David M Panicek
Journal:  Int Orthop       Date:  2013-02-23       Impact factor: 3.075

Review 6.  Diagnostic Advances in Multiple Myeloma.

Authors:  Kevin Barley; Ajai Chari
Journal:  Curr Hematol Malig Rep       Date:  2016-04       Impact factor: 3.952

7.  Comparison of a new whole-body continuous-table-movement protocol versus a standard whole-body MR protocol for the assessment of multiple myeloma.

Authors:  S Weckbach; H J Michaely; A Stemmer; S O Schoenberg; D J Dinter
Journal:  Eur Radiol       Date:  2010-06-24       Impact factor: 5.315

Review 8.  Current and future imaging modalities for multiple myeloma and its precursor states.

Authors:  Esther Tan; Brendan M Weiss; Esther Mena; Neha Korde; Peter L Choyke; Ola Landgren
Journal:  Leuk Lymphoma       Date:  2011-06-08

Review 9.  Bone disease in multiple myeloma and precursor disease: novel diagnostic approaches and implications on clinical management.

Authors:  Sigurdur Y Kristinsson; Alex R Minter; Neha Korde; Esther Tan; Ola Landgren
Journal:  Expert Rev Mol Diagn       Date:  2011-07       Impact factor: 5.225

Review 10.  Role of radiography, MRI and FDG-PET/CT in diagnosing, staging and therapeutical evaluation of patients with multiple myeloma.

Authors:  Susanne Lütje; Jacky W J de Rooy; Sandra Croockewit; Emmeline Koedam; Wim J G Oyen; Reinier A Raymakers
Journal:  Ann Hematol       Date:  2009-12       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.